Equities

Neogen Corp

Neogen Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)15.18
  • Today's Change-0.16 / -1.04%
  • Shares traded1.94m
  • 1 Year change+3.62%
  • Beta1.2301
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of May 31 2024202420232022
ASSETS
Cash And Short Term Investments171246381
Total Receivables, Net173153100
Total Inventory189134122
Prepaid expenses565324
Other current assets, total------
Total current assets589586627
Property, plant & equipment, net292211114
Goodwill, net2,1362,137143
Intangibles, net1,5121,605108
Long term investments------
Note receivable - long term------
Other long term assets20152.16
Total assets4,5494,554993
LIABILITIES
Accounts payable837735
Accrued expenses545736
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.45----
Other current liabilities, total15127.59
Total current liabilities15414578
Total long term debt8888850
Total debt8918850
Deferred income tax32735317
Minority interest------
Other liabilities, total353611
Total liabilities1,4051,420106
SHAREHOLDERS EQUITY
Common stock353517
Additional paid-in capital2,5842,568310
Retained earnings (accumulated deficit)556565588
Treasury stock - common------
Unrealized gain (loss)----(2.28)
Other equity, total(30)(33)(25)
Total equity3,1443,134887
Total liabilities & shareholders' equity4,5494,554993
Total common shares outstanding217216108
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.